Home / Cancer and immune system / Lapatinib
ATC L01XE07 · Protein Kinase Inhibitors · updated 2 Nov 2026
Lapatinib shortage
As of 2 Nov 2026, Lapatinib has a reported shortage in 1 of the 16 countries we track (Japan), covering 1 product from 1 company.
Is there a Lapatinib shortage?
Yes. As of 2 Nov 2026, Lapatinib is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novartis NOVN · SIX Swiss
Compared with similar medicines
ATC group L01XE · Protein Kinase InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | タイケルブ錠250mg limited | Novartis | 15 Sep 2026 | not given | Quality problem or recall Quality problem |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Lapatinib shortage?
Yes. As of 2 Nov 2026, Lapatinib is reported short in 1 of the 16 countries we track: Japan. No company has given a return date.
When will Lapatinib be back in stock?
No return date has been given; Japan: no date given. These are company estimates reported to each authority.
Why is Lapatinib in short supply?
The most common reason reported is: quality problem or recall. Reasons by product are listed in the table below.
Which companies have Lapatinib shortages?
Novartis.